Gibbs Wealth Management Vericel Corp Transaction History
Gibbs Wealth Management
- $442 Billion
- Q3 2025
A detailed history of Gibbs Wealth Management transactions in Vericel Corp stock. As of the latest transaction made, Gibbs Wealth Management holds 13,262 shares of VCEL stock, worth $528,623. This represents 0.09% of its overall portfolio holdings.
Number of Shares
13,262
Previous 15,205
12.78%
Holding current value
$528,623
Previous $647 Million
35.49%
% of portfolio
0.09%
Previous 0.12%
Shares
6 transactions
Others Institutions Holding VCEL
# of Institutions
274Shares Held
52.6MCall Options Held
36.6KPut Options Held
9.1K-
Black Rock Inc. New York, NY8.06MShares$321 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$140 Million0.0% of portfolio
-
State Street Corp Boston, MA2.81MShares$112 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.21MShares$88.1 Million0.19% of portfolio
-
Conestoga Capital Advisors, LLC2.18MShares$86.7 Million1.1% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.88B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...